Laboratory Corporation of America Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Laboratory of America Holdings has a total shareholder equity of $7.9B and total debt of $5.1B, which brings its debt-to-equity ratio to 64.1%. Its total assets and total liabilities are $16.7B and $8.8B respectively. Laboratory of America Holdings's EBIT is $1.1B making its interest coverage ratio 6.5. It has cash and short-term investments of $536.8M.
Key information
64.1%
Debt to equity ratio
US$5.05b
Debt
| Interest coverage ratio | 6.5x |
| Cash | US$536.80m |
| Equity | US$7.89b |
| Total liabilities | US$8.83b |
| Total assets | US$16.73b |
Recent financial health updates
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt
Oct 14Recent updates
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt
Oct 14Laboratory Corporation of America declares $0.72 dividend
Oct 12Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?
Sep 28LabCorp to pay $273M to company for infringing prenatal test patents - Bloomberg
Sep 23LabCorp: Drug Development Segment Spinoff Poised To Generate Significant Value
Aug 23Financial Position Analysis
Short Term Liabilities: LH's short term assets ($3.8B) exceed its short term liabilities ($3.2B).
Long Term Liabilities: LH's short term assets ($3.8B) do not cover its long term liabilities ($5.6B).
Debt to Equity History and Analysis
Debt Level: LH's net debt to equity ratio (57.3%) is considered high.
Reducing Debt: LH's debt to equity ratio has reduced from 85.8% to 64.1% over the past 5 years.
Debt Coverage: LH's debt is well covered by operating cash flow (26.3%).
Interest Coverage: LH's interest payments on its debt are well covered by EBIT (6.5x coverage).